This trial is testing a drug called cobimetinib to see if it can help kids and adults with Langerhans cell histiocytosis (LCH) who have relapsed or who haven't responded to other treatments.
1 Primary · 2 Secondary · Reporting Duration: 12 months
90 Total Participants · 4 Treatment Groups
Primary Treatment: Cobimetinib · No Placebo Group · Phase 2
Age Any Age · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: